A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Marconi, Raffaella ^a   Strolin, Silvia ^a   Bossi, Gianluca ^a   Strigari, Lidia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCOPAL EFFECT; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CLINICAL PRACTICE; COLON CANCER; EFFECTIVE DOSE (RADIATION); FIBROSARCOMA; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MELANOMA; META ANALYSIS; MURINE MODEL; NONHUMAN; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PANCREAS CANCER; PRECLINICAL STUDY; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC PROCEDURE; ANIMAL; FEMALE; IMMUNOTHERAPY; MALE; METHODOLOGY; MOUSE; MULTIMODALITY CANCER THERAPY; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PATHOPHYSIOLOGY; RADIOSURGERY; RADIOTHERAPY DOSAGE; STATISTICAL MODEL; TUMOR VOLUME;

ANIMALS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; IMMUNOTHERAPY; LIKELIHOOD FUNCTIONS; MALE; MICE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; RADIOSURGERY; RADIOTHERAPY DOSAGE; RESEARCH DESIGN; TUMOR BURDEN;

EID: 85013301355     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0171559     Document Type: Article

References (60)

1. Aneja S, Yu JB. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol. 2014 Jan; 24(1):35-42. doi: 10.1016/j. semradonc.2013.08.004 PMID: 24314340
2. Bert C, Durante M. Particle radiosurgery: a new frontier of physics in medicine. Phys Med. 2014 Jul; 30 (5):535-8. doi: 10.1016/j.ejmp.2014.04.011 PMID: 24889154
3. Mole RH. Whole body irradiation; radiobiology or medicine? Br J Radiol. 1953; 26(305):234-41. doi: 10. 1259/0007-1285-26-305-234 PMID: 13042090
4. Chai Y, Hei TK. Radiation Induced Bystander Effect in vivo. Acta Med Nagasaki. 2008; 53:S65-S69. PMID: 20634916
5. Butterworth KT, McMahon SJ, Hounsell AR, O'Sullivan JM, Prise KM. Bystander signalling: exploring clinical relevance through new approaches and new models. Clin Oncol (R Coll Radiol). 2013 Oct; 25 (10):586-92.
6. Kaur P, Asea A. Radiation-induced effects and the immune system in cancer. Front Oncol. 2012 Dec 17; 2:191. doi: 10.3389/fonc.2012.00191 PMID: 23251903
7. Sperduto PW, Song CW, Kirkpatrick JP, Glatstein E. A hypothesis: indirect cell death in the radiosurgery era. Int J Radiat Oncol Biol Phys. 2015 Jan 1; 91(1):11-3. doi: 10.1016/j.ijrobp.2014.08.355 PMID: 25835617
8. Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys. 2014 Feb 1; 88(2):254-62. doi: 10.1016/j.ijrobp.2013.07.022 PMID: 24411596
9. Hellevik T, Martinez-Zubiaurre I. Radiotherapy and the tumor stroma: the importance of dose and fractionation. Front Oncol. 2014 Jan 21; 4:1. doi: 10.3389/fonc.2014.00001 PMID: 24478982
10. Song CW, Cho LC, Yuan J, Dusenbery KE, Griffin RJ, Levitt SH. Radiobiology of stereotactic body radiation therapy/stereotactic radiosurgery and the linear-quadratic model. Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87(1):18-9. doi: 10.1016/j.ijrobp.2013.03.013 PMID: 23608235
11. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: Implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 2012 Mar; 177(3):311-27. PMID: 22229487
12. Siva S, MacManus MP, Martin RF, Martin OA. Abscopal effects of radiation therapy: a clinical review for the radiobiologist. Cancer Lett. 2015 Jan 1; 356(1):82-90. doi: 10.1016/j.canlet.2013.09.018 PMID: 24125863
13. Reynders K, Illidge T, Siva S, Chang JY, De Ruysscher D. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant. Cancer Treat Rev. 2015 Jun; 41(6):503-10. doi: 10.1016/j.ctrv.2015.03.011 PMID: 25872878
14. Corvò R, Belgioia L. Synergy between radiotherapy and immunotherapy in the treatment of advanced malignancies: recent evidences of a new challenge in oncology. Recent Prog Med. 2015 Jul; 106 (7):322-30.
15. Strigari L, Mancuso M, Ubertini V, Soriani A, Giardullo P, Benassi M, et al. Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status. Int J Radiat Biol. 2015 Mar; 91(3):294. doi: 10.3109/09553002.2014.997514 PMID: 25650895
16. Fowler JF. A Review: The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62:679-675. doi: 10.1259/0007-1285-62-740-679 PMID: 2670032
17. Fowler JF. 21 years of biologically effective dose. Br J Radiol. 2010 Jul; 83(991):554-68. doi: 10.1259/ bjr/31372149 PMID: 20603408
18. Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC, et al. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res. 2005 Dec 15; 11(24 Pt 1):8773-81.
19. Böhnke A, Westphal F, Schmidt A, El-Awady RA, Dahm-Daphi J. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells. Int J Radiat Biol. 2004 Jan; 80 (1):53-63.
20. Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, et al. Cancer Res. 2003 Apr 15; 63(8):1990-3. PMID: 12702593
21. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys. 2004 Mar 1; 58(3):862-70. doi: 10.1016/j.ijrobp.2003.09.012 PMID: 14967443
22. Dewan MZ, Galloway AE, Kawashima N, Dewyngaert JK, Babb JS, Formenti SC, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res. 2009 Sep 1; 15(17):5379-88. doi: 10.1158/1078-0432.CCR- 09-0265 PMID: 19706802
23. Akutsu Y, Matsubara H, Urashima T, Komatsu A, Sakata H, Nishimori T, et al. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Int J Oncol. 2007 Sep; 31(3):509-15. PMID: 17671676
24. Shiraishi K, Ishiwata Y, Nakagawa K, Yokochi S, Taruki C, Akuta T, et al. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin Cancer Res. 2008 Feb 15; 14(4):1159-66. doi: 10.1158/ 1078-0432.CCR-07-4485 PMID: 18281550
25. Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014 Feb; 124(2):687-95. doi: 10.1172/JCI67313 PMID: 24382348
26. Kanegasaki S, Matsushima K, Shiraishi K, Nakagawa K, Tsuchiya T. Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy. Cancer Res. 2014 Sep 15; 74(18):5070-8. doi: 10.1158/0008-5472.CAN-14-0551 PMID: 25038226
27. Chakravarty PK, Alfieri A, Thomas EK, Beri V, Tanaka KE, Vikram B, et al. Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. Cancer Res. 1999 Dec 15; 59(24):6028-32. PMID: 10626784
28. Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, et al. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Cancer Res. 2003 Dec 1; 63 (23):8466-75. PMID: 14679011
29. Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):728-34.
30. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009 Jul 16; 114 (3):589-95. doi: 10.1182/blood-2009-02-206870 PMID: 19349616
31. Yasuda K, Nirei T, Tsuno NH, Nagawa H, Kitayama J. Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer. Cancer Sci. 2011 Jul; 102 (7):1257-63. doi: 10.1111/j.1349-7006.2011.01940.x PMID: 21443690
32. Burnette B, Weichselbaum RR. The immunology of ablative radiation. Semin Radiat Oncol. 2015 Jan; 25(1):40-5. doi: 10.1016/j.semradonc.2014.07.009 PMID: 25481265
33. Lindsay KJ, Coates PJ, Lorimore SA, Wright EG. The genetic basis of tissue responses to ionizing radiation. Br J Radiol. 2007 Sep; 80 Spec No 1:S2-6. doi: 10.1259/bjr/60507340 PMID: 17704322
34. Kataoka T, Mizuguchi Y, Notohara K, Taguchi T, Yamaoka K. Histological changes in spleens of radiosensitive and radio-resistant mice exposed to low- dose X-ray irradiation. Physiol Chem Phys Med NMR. 2006; 38(1):21-9. PMID: 17405409
35. Wallace M, Coates PJ, Wright EG, Ball KL. Differential post-translational modification of the tumor suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo. Oncogene. 2001 Jun 21; 20(28):3597-608. doi: 10.1038/sj.onc.1204496 PMID: 11439323
36. Mori N, Matsumoto Y, Okumoto M, Suzuki N, Yamate J. Variations in Prkdc encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and susceptibility to radiation-induced apoptosis and lymphomagenesis. Oncogene. 2001 Jun 21; 20(28):3609-19. doi: 10.1038/sj.onc.1204497 PMID: 11439324
37. Rodgers BE, Chesser RK, Wickliffe JK, Phillips CJ, Baker RJ. Subchronic exposure of BALB/c and C57BL/6 strains of Mus musculus to the radioactive environment of the Chornobyl, Ukraine exclusion zone. Environ Toxicol Chem. 2001 Dec; 20(12):2830-5. PMID: 11764167
38. Basu D, Herlyn M. Defining microenvironments within mouse models that enhance tumor aggressiveness. Cancer Biol Ther. 2009 Feb; 8(4):380-1. PMID: 19182538
39. Yu Y, Okayasu R, Weil MM, Silver A, McCarthy M, Zabriskie R, et al. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res. 2001 Mar 1; 61(5):1820-4. PMID: 11280730
40. Belizário JE. Immunodeficient Mouse Models: An Overview. Open Immunol J. 2009; 2:79-85.
41. Ikehara S, Pahwa RN, Fernandes G, Hansen CT, Good RA. Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A. 1984 Feb; 81(3):886-8. PMID: 6608104
42. Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009 Jul; 10(7):718-26. doi: 10.1016/S1470-2045(09)70082-8 PMID: 19573801
43. Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JC. Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat Med. 1997 Jun; 3(6):625-31. PMID: 9176488
44. Crittenden M, Kohrt H, Levy R, Jones J, Camphausen K, Dicker A, et al. Current clinical trials testing combinations of immunotherapy and radiation. Semin Radiat Oncol. 2015 Jan; 25(1):54-64. doi: 10. 1016/j.semradonc.2014.07.003 PMID: 25481267
45. Chandra RA, Wilhite TJ, Balboni TA, Alexander BM, Spektor A, Ott PA, et al. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology. 2015 May 28; 4(11):e1046028. eCollection 2015. doi: 10.1080/2162402X. 2015.1046028 PMID: 26451318
46. Strigari L, Pinnarò P, Carlini P, Torino F, Strolin S, Minosse S, et al. Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the headand-neck in the light of a novel mathematical model. Crit Rev Oncol Hematol. 2016 Jun; 102:101-10. doi: 10.1016/j.critrevonc.2016.04.004 PMID: 27157527
47. Strigari L, D'Andrea M, Abate A, Benassi M. A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability. Phys Med Biol. 2008 Oct 7; 53(19):5257-73. doi: 10.1088/0031-9155/53/19/001 PMID: 18758004
48. Golden EB, Chhabra A, Chachoua A, Adams S, Donach M, Fenton-Kerimian M, et al. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumors: a proof-of-principle trial. Lancet Oncol. 2015 Jul; 16(7):795-803. doi: 10. 1016/S1470-2045(15)00054-6 PMID: 26095785
49. Golden EB, Formenti SC. Is tumor (R)ejection by the immune system the "5th R" of radiobiology?, Oncoimmunology, 2014 Jan 1; 3(1):e28133. doi: 10.4161/onci.28133 PMID: 24800177
50. Demaria S, Formenti SC. Radiotherapy effects on anti-tumor immunity: implications for cancer treatment. Front Oncol. 2013 May 22; 3:128. doi: 10.3389/fonc.2013.00128 PMID: 23734344
51. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut. 1998 Oct; 43(4):575-7. PMID: 9824589
52. Blyth BJ, Sykes PJ. Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures? Radiat Res. 2011 Aug; 176(2):139-57. PMID: 21631286
53. Asur R, Butterworth KT, Penagaricano JA, Prise KM, Griffin RJ. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015 Jan 1; 356(1):52-7. doi: 10.1016/j.canlet.2013.10.032 PMID: 24246848
54. Sologuren I, Rodríguez-Gallego C, Lara PC. Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects. Transl Canc Res. 2014; 3:18-31.
55. Lorimore SA, Rastogi S, Mukherjee D, Coates PJ, Wright EG. The influence of p53 functions on radiation-induced inflammatory bystander-type signaling in murine bone marrow. Radiat Res. 2013 Apr; 179 (4):406-15. doi: 10.1667/RR3158.2 PMID: 23578188
56. Rastogi S, Boylan M, Wright EG, Coates PJ. Interactions of apoptotic cells with macrophages in radiation-induced bystander signaling. Radiat Res. 2013 Feb; 179(2):135-45. doi: 10.1667/RR2969.1 PMID: 23237586
57. Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Dev. 2013 Feb; 23(1):12-9. doi: 10.1016/j.gde.2013.01.002 PMID: 23453900
58. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009 May; 9(5):351-60. doi: 10.1038/nrc2603 PMID: 19377507
59. Staffurth J, Radiotherapy Development Board (14 collaborators). A review of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (RCollRadiol) 2010 Oct; 22(8):643-57.
60. McGarry CK, Butterworth KT, Trainor C, McMahon SJ, O'Sullivan JM, Prise KM, et al. In-vitro investigation of out-of-field cell survival following the delivery of conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) plans. Phys Med Biol. 2012 Oct 21; 57 (20):6635-45. doi: 10.1088/0031-9155/57/20/6635 PMID: 23022685